Loading viewer...
conference
Format: PDF conference
Axsome Therapeutics presented an overview of its business and clinical pipeline at the BIO CEO & Investor Conference in February 2017. The presentation highlighted the company's late-stage clinical product candidates AXS-05 and AXS-02, delivered by CEO Herriot Tabuteau, M.D.
presentation
conference
64 Pages
Cargotec
Naval Academy Alumni Volunteer Leader Summit 2024
conferenceconference
4 Pages
U.S. Naval Academy Alumni Association and Foundation